Combinations ; See Below
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Canditral | Glenmark | Galaxy Pharmaceuticals Ltd | 100mg | 12 | Capsule | per capsule | KES 1,675.00 |
| Fulcover | Saga Laboratories | Pharmaken Ltd | 100mg | 10 | Capsule | per capsule | KES 993.00 |
| Icon | Ferozsons Laboratories Ltd | Surgilinks Ltd. | 100mg | 4 | Capsule | per capsule | KES 250.00 |
| Intranox | Adwia | Salama Pharmaceuticals Ltd. | 100mg | 15 | Capsule | per capsule | KES 1,670.00 |
| Itacare | Micro - Labs Limited | Harley's Limited | 100mg | 30 | Tablet | per tablet | KES 3,250.00 |
| Itracon | Global Pharma Healthcare Pvt. Ltd | Galaxy Pharmaceuticals Ltd | 100mg | 4 | Capsule | per capsule | KES 450.00 |
| Itranox | Coral Laboratories Ltd | Signature Healthcare Limited | 100mg | 4 | Capsule | per capsule | KES 325.00 |
| Sporanox | Janssen Cilag | Laborex Kenya Eurapharma Ltd | 100mg | 14 | Capsule | per capsule | KES 3,516.00 |
| Itraconazole More info | |
|---|---|
| Mode Of Action | Fluconazole nhibits the fungal cytochrome P-450 3-A dependent enzyme, 14-alpha demethylase interrupting synthesis of ergosterol and resulting in increased cellular permeability and loss of cell contents |
| Drug Indication | Vulvovaginal candidiasis, Tinea corporis, tinea cruris, oral candidiasis, Tinea pedis and tinea manuum, Pityriasis versicolor |
| Side Effects | Are moderate, systemic hypertension, reversible nephrotic syndrome, nausea and vomiting, diarrhoea, loss of libido and pruritis. |
| Dosage | Vulvovaginal candidiasis; 200mg BD x 1/7. Tinea corporis, tinea cruris, oral candidiasis; 100mg OD x 15/7. Tinea pedis and tinea manuum; 100mg OD 30/7. Pityriasis versicolor; 200mg daily for 1/52. |
| Pregnancy Category | Category B3 |
| Pregnancy Category Description | Drugs which have been taken by only a small number of pregnant women and women of child-bearing age with no any established rise in the frequency of malformations or other direct or indirect detrimental effects on the foetus having been noted. Studies in animals show evidence of an increased occurrence of foetal damage, the significance of which is uncertain in human |
| Drug Category | DRUGS ACTING ON INFECTIONS |
| Drug Sub-Category | Anti-Fungals |